Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ORIC held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Nextech Invest, Ltd. | 7.2M | $90.8M | 0.0% | 6.919% | 6.39% |
| 2 | EcoR1 Capital, LLC | 6.7M | $85.2M | 0.0% | 6.499% | 3.62% |
| 3 | BlackRock, Inc. | 6.0M | $75.8M | +1.9% | 5.781% | 0.00% |
| 4 | VIKING GLOBAL INVESTORS LP | 5.8M | $73.8M | -11.4% | 5.627% | 0.21% |
| 5 | SR ONE CAPITAL MANAGEMENT, LP | 4.5M | $58.5M | 0.0% | 4.362% | 6.39% |
| 6 | PFIZER INC | 4.8M | $57.7M | -11.1% | 4.618% | 24.14% |
| 7 | ALKEON CAPITAL MANAGEMENT LLC | 4.5M | $57.1M | 0.0% | 4.351% | 0.35% |
| 8 | VR Adviser, LLC | 4.3M | $54.7M | -23.9% | 4.173% | 2.04% |
| 9 | NEA Management Company, LLC | 4.1M | $52.2M | 0.0% | 3.979% | 2.97% |
| 10 | STATE STREET CORP | 3.7M | $46.9M | -13.1% | 3.576% | 0.00% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | $46.7M | β | 3.562% | 0.00% |
| 12 | Column Group LLC | 3.5M | $44.9M | 0.0% | 3.421% | 44.55% |
| 13 | Siren, L.L.C. | 3.0M | $38.0M | +197.6% | 2.896% | 1.05% |
| 14 | ORBIMED ADVISORS LLC | 2.7M | $34.1M | -26.0% | 2.602% | 0.72% |
| 15 | AIHC Capital Management Ltd | 2.5M | $31.2M | β | 2.376% | 26.04% |
| 16 | FMR LLC | 2.4M | $30.8M | -1.8% | 2.351% | 0.00% |
| 17 | CITADEL ADVISORS LLC | 2.4M | $30.8M | -0.7% | 2.350% | 0.01% |
| 18 | First Turn Management, LLC | 2.0M | $25.6M | +0.4% | 1.949% | 2.86% |
| 19 | Vivo Capital, LLC | 1.8M | $23.4M | -12.7% | 1.786% | 1.95% |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $23.3M | +5.0% | 1.776% | 0.00% |
| 21 | MPM Oncology Impact Management LP | 1.8M | $22.9M | +0.3% | 1.743% | 1.77% |
| 22 | Paradigm Biocapital Advisors LP | 1.7M | $21.6M | -29.1% | 1.643% | 0.44% |
| 23 | MORGAN STANLEY | 1.7M | $21.3M | +40.9% | 1.625% | 0.00% |
| 24 | GOLDMAN SACHS GROUP INC | 1.5M | $18.7M | -23.9% | 1.426% | 0.00% |
| 25 | DIMENSIONAL FUND ADVISORS LP | 1.5M | $18.6M | +19.9% | 1.421% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ORIC β a direct measure of their conviction.
Filings activity in ORIC during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ORIC position in Q1 2026
Institutions that fully closed their ORIC position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 176 | +8.0% | 166.52% | +56.09 pp | $1.43B | +51% |
| Q4 2025 | 163 | +13% | 110.43% | 34.56 pp | $945M | 24% |
| Q3 2025 | 144 | +3.6% | 144.99% | +38.07 pp | $1.24B | +36% |
| Q2 2025 | 139 | 1.4% | 106.92% | +56.74 pp | $915M | +113% |
| Q1 2025 | 141 | +9.3% | 50.18% | 18.36 pp | $430M | 27% |
| Q4 2024 | 129 | +6.6% | 68.54% | 13.23 pp | $587M | 16% |
| Q3 2024 | 121 | +7.1% | 81.77% | +27.09 pp | $700M | +50% |
| Q2 2024 | 113 | β | 54.68% | β | $468M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ORIC stock.
Based on Q1 2026 13F filings, institutional ownership of ORIC Pharmaceuticals, Inc. stands at 166.5%, held across 176 reporting institutions.
Nextech Invest, Ltd. is the largest reported institutional holder of ORIC, with approximately 7,162,637 shares worth $0.09B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of ORIC, including VIKING GLOBAL INVESTORS LP, CITADEL ADVISORS LLC.
Our composite Smart Money Score for ORIC is 68 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
39 institutions opened new positions in ORIC during Q1 2026, while 26 fully exited. 110 added to existing positions and 26 trimmed.
ORIC institutional ownership rose by 56.09 percentage points quarter-over-quarter, with a net change of +13 holders.
The top 10 institutions account for 45.8% of all reported 13F value in ORIC, and the top 25 account for 76.1%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
ORIC Pharmaceuticals, Inc. (ORIC) Institutional Ownership